Simulteneous determination of olmesartan medoxomil and amlodipine besylate from tablet formulation by multiwavelength method

International Journal of ChemTech Research

Volumn 3, Issue 1, 2011, Pages 267-273

  Patil Pournima, S ^a   Chivate Niranjan, D ^a   Shinde Shubhangi, S ^a   More Harinath, N ^b   Pishwikar Sachin, A ^b  

^a KCT's Krishna College of Pharmacy   (India)

^b BHARATI VIDYAPEETH COLLEGE OF PHARMACY   (India)

Author keywords

Amlodipine besylate; Olmesartan medoxomil; Specroscopy

Indexed keywords

AMLODIPINE BESYLATE; METHANOL; OLMESARTAN;

ACCURACY; ARTICLE; DRUG DETERMINATION; QUANTITATIVE ANALYSIS; SPECTROPHOTOMETRY; TABLET FORMULATION;

EID: 79951479056     PISSN: None     EISSN: 09744290     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Skoog D. A., West D. M. and Holler F. J., Analytical Chemistry An Introduction, Saunders College of Publishing, Philadelphia 1994, 1-3.
2. Skoog D. A. and Leary J. J., Principles of Instrumental Analysis, Saunders College of Publishing, Philadelphia 1992,1-2.
3. Merck Index, An encyclopedia of chemicals, drugs and biologicals, Merck research laboratories division of Merck & Co, USA, 615,3605.
4. The United State Pharmacopoeia. USP Convention, Rockville 2009, 532, 2247.
5. Dongyang L., Pei H. and Matsushima N., Quantitative determination of olmesartan in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry. J. Chromatography B. 856 (2007) 190-197; DOI: 10.1016/j.jchromb.2007.05.049.
6. Vaidya V. V. and Shikha, M. N. LC-MS-MS Determination of Olmesartan in Human Plasma. Chromatographia. 67 (2008) 147-150; DOI: 10.1365/s10337-007-0453-x.
7. Nakamoto T. and Harasawa H., Effects of a olmesartan medoxomil as an angiotensin IIreceptor blocker in chronic hypoxic rats. European J. Pharmacology, 528 (2005) 43-51.DOI: PMID: 16336959.
8. Nakamura H. and Inoue T., Pharmacological and pharmacokinetic study of Olmesartan medoxomil in animal diabetic retinopathy models. European J. Pharmacology, 512 (2005) 239-246; DOI PMID: 15840410.
9. Brunner H R, The new oral angiotensin II antagonist olmesartan medoxomil: a concise overview. Journal of Human Hypertension, 16 (2002) 13-16. DOI: 10.1038/sj/jhh/1001391.
10. Shah D. A., Bhatt K. K., Shankar M. B., Mehta R. S., Gandhi T. R. and Baldania S. L., RP-HPLC determination of atorvastatin calcium and amlodipine besylate combination in tablets. Ind. J. Pharm. Sci. 68 (2006) 796-799; DOI: 10.4103/0250-474X.31019.
11. Naidu K. R., Kale U. N. and Shingare M. S., Stability indicating RP-HPLC method for simultaneous determination of amlodipine and benazepril hydrochloride from their combination drug product. J. Pharm. Biomed. Anal. 39 (2005) 147-155; DOI: PMID: 15939562.
12. Shau R. and Patel V. B., Simultaneous spectrophotometric determination of amlodipine besylate and atorvastatin calcium in binary mixture. Ind. J. Pharm. Sci. 69 (2007) 110-111; DOI: ISSN 0250-474X.
13. Rahman N. and Hoda M. N., Validated spectrophotometric methods for the determination of amlodipine besylate in drug formulations using 2,3-dichloro 5,6-dicyano 1,4-benzoquinone and ascorbic acid. J. Pharm. Biomed. Anal. 31 (2003) 381-392; DOI: 10.1016/S0731-7085(02)00610-6.
14. Sridhar K, Sastry C. S. P., Reddy M. N., Sankar D. G and Srinivas K. Rama, Spectrophotometric Determination of Amlodipine Besylate in Pure Forms and Tablets, Analytical Letteres 30 (1997), 121-133; DOI: 10.1080/00032719708002295.
15. Rahman N. and Azmi S. N. H., Spectrophotometric method for the determination of amlodipine besylate with ninhydrin in drug formulations. II Farmaco, 56 (2001) 731-735.DOI: 10.1016/S0014-827X(01)01093-X.
16. Kasture AV, Ramteke M, Simultaneous UVSpectrophotometric method for the estimation of atenolol and amlodipine besylate in combined dosage form. Ind. J. Pharm. Sci. 68 (2006); 394-396.
17. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Stability testing of new drug substances and products, Q1A(R2), Current step 4 version dated 6 February 2003; http://www.ich.org.